Steven Hyman discusses the use of disease model systems to study neuropsychiatric and neurodevelopmental conditions, highlighting their benefits and limitations, and stressing the importance of knowing what questions to address in each system.
SFARI Conversations
SFARI senior scientist Alan Packer, SPARK director Pamela Feliciano, and former Simons Searchlight outreach manager Misia Kowanda discuss differences and similarities between the ASD gene lists maintained by SFARI, SPARK and Simons Searchlight.
Subscribe to our newsletter and receive SFARI funding announcements and news
A Conversation with SFARI consultant-in-residence Gaspar Taroncher-Oldenburg
SFARI consultant-in-residence Gaspar Taroncher-Oldenburg discusses his work and collaboration with the Simons Foundation Flatiron Institute to study the microbiome and its potential implications for ASD research.
A Conversation with SFARI BTI and SEED awardee J. Elliott Robinson
J. Elliott Robinson talks about his lab’s work on the neural circuits involved in neurofibromatosis type 1 and developing gene therapy treatments for the condition, and how the SFARI BTI and SEED awards have aided these efforts.
A Conversation with SFARI Bridge to Independence Investigator Aakanksha Singhvi
SFARI Investigator Aakanksha Singhvi discusses her lab’s work and how the Bridge to Independence Award helped in her transition to working as an assistant professor.
A Conversation with SFARI Investigator Kevin Eggan
SFARI Investigator Kevin Eggan discusses his research on induced pluripotent stem (iPS) cells and his collaboration with SFARI to provide a detailed characterization of iPS cell lines from Simons Searchlight participants.
A Conversation with SFARI Investigators Peter Kind and Loren Frank
Peter Kind and Loren Frank discuss their work using SFARI’s genetic rat models and their views on how these models will aid autism research.
A Conversation with SFARI Investigator Karen Parker
SFARI Investigator Karen Parker discusses her preclinical and clinical research on the neuropeptides arginine vasopressin and oxytocin as potential biomarkers and treatment strategies for autism spectrum disorder.
A Conversation with SFARI Investigator Dan Feldman
SFARI Investigator Dan Feldman discusses the E-I ratio hypothesis in autism and his lab’s recent studies that aimed to test it.
A Conversation with SFARI Bridge to Independence Investigator Seth Shipman
SFARI Investigator Seth Shipman discusses his lab’s research on the molecular and cellular mechanisms shaping brain development and how the Bridge to Independence Award is helping him launch his independent research career.
- Previous Page
- Viewing
- Next Page